Wednesday, April 10, 2019, Anaheim, California, 11:15 AM – 12:45 PM

Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice — A 6-Part CNE Symposia Series Held During the ONS 44th Annual Congress

PART 1 — Gastrointestinal Cancers

Location:
Anaheim Marriott
700 West Convention Way
Anaheim, CA 92802
Hotel Phone: (714) 750-8000

Meeting Room:
Grand Ballroom E-K (Lobby Level)
Schedule:
10:45 AM – 11:15 AM
Registration and Lunch Buffet

11:15 AM – 12:45 PM
Educational Program
 
There is no registration fee for this event. Preregistration is highly recommended as seating and meal service are limited.

Faculty:
Jessica Mitchell, RN, CNP, MPH
Assistant Professor of Oncology
Mayo College of Medicine
Rochester, Minnesota

Eileen M O’Reilly, MD
Winthrop Rockefeller Chair in Medical Oncology
Section Head
Hepatopancreaticobiliary/Neuroendocrine Cancers
Gastrointestinal Oncology Service
Associate Director

David M Rubenstein Center for Pancreatic Cancer
Attending Physician, Member
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York

Philip A Philip, MD, PhD
Kathryn Cramer Endowed Chair in Cancer Research
Professor of Oncology and Pharmacology
Leader, GI and Neuroendocrine Oncology
Vice President of Medical Affairs
Karmanos Cancer Institute
Wayne State University
Detroit, Michigan

Amanda Wagner, APRN-CNP, AOCNP
The Arthur G James Cancer Hospital
Martha Morehouse Plaza
GI Medical Oncology
Columbus, Ohio

Moderator:
Neil Love, MD
Research To Practice
Miami, Florida
 
Meeting space has been assigned to provide a symposium supported by Eisai Inc, Exelixis Inc, Ipsen Biopharmaceuticals Inc, Lilly, Merck and Taiho Oncology Inc during the Oncology Nursing Society’s (ONS) 44th Annual Congress, April 11-14, 2019 in Anaheim, California. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.
10:45 AM – 11:15 AM — Registration and Lunch Buffet
11:15 AM – 12:45 PM — Educational Program

Cases Presented Will Include Discussion of the Following Topics:

  • Existing and emerging treatment strategies for metastatic hepatocellular carcinoma
  • Optimal sequence and selection of systemic therapy for advanced gastric, gastroesophageal junction and esophageal cancer
  • Long-term management of metastatic colorectal cancer
  • Therapeutic decision-making for patients with localized, locally advanced and metastatic pancreatic adenocarcinoma
A detailed agenda will be available in the coming weeks

Target Audience:
This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of gastrointestinal (GI) cancers.

Learning Objectives and Goals:
Upon completion of this activity, participants should be able to:

  • Apply available research data to the therapeutic and supportive care of patients with colorectal cancer (CRC), gastroesophageal cancer, pancreatic cancer and hepatocellular carcinoma (HCC).
  • Recognize the importance of biomarker analysis for patients diagnosed with CRC or gastric/gastroesophageal junction (GEJ)/esophageal cancer, and use this information to counsel these individuals regarding the selection of evidence-based systemic treatment options.
  • Describe the clinical indications, benefits and toxicities associated with the use of existing and recently approved systemic therapies in the management of metastatic CRC.
  • Use HER2 status, PD-L1 combined positive score, clinical factors and patient preferences to optimize systemic therapy for locally advanced or metastatic gastric/GEJ/esophageal cancer.
  • Consider age, performance status and other clinical and logistical factors in the selection of systemic therapy for patients with localized, locally advanced or metastatic pancreatic cancer.
  • Communicate the benefits and risks of approved and emerging systemic interventions to patients with locally advanced or metastatic HCC.
  • Appraise the rationale for and clinical data with commercially available and developmental immune checkpoint inhibitors in the treatment of GI cancers.
Accreditation Statement:
Research To Practice (RTP) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation.

Credit Designation Statements:
This educational activity for 1.5 contact hours is provided by RTP.

This activity is awarded 1.5 ANCC pharmacotherapeutic contact hours.

To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity.

Oncology Nursing Certification Corporation (ONCC)/Individual Learning Needs Assessment (ILNA) Certification Information:
This activity will be submitted to the ONCC for ILNA verification.

Unlabeled/Unapproved Uses Notice:
There is no implied or real endorsement of any product by RTP or the ANCC. Any off-label use as declared by the FDA will be identified.

Content Validation and Disclosures:
RTP is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

RTP CME/CNE planning committee members, staff and reviewers — Planners, scientific staff and independent reviewers for RTP have no relevant conflicts of interest to disclose.

Supporters:
This activity is supported by educational grants from Eisai Inc, Exelixis Inc, Ipsen Biopharmaceuticals Inc, Lilly, Merck and Taiho Oncology Inc.

Anaheim Marriott
700 West Convention Way
Anaheim, CA 92802
Hotel Phone: (714) 750-8000

Meeting Room: 
Grand Ballroom E-K (Lobby Level)

The Anaheim Marriott is the headquarters hotel for the 2019 ONS Congress and is conveniently located near the Anaheim Convention Center (0.2 miles).

 

This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and clinical nurse specialists involved in the treatment of gastrointestinal cancers.

There is no registration fee for this event. However, preregistration is highly recommended as seating is limited.

Registration for clinicians in practice

• I am a practicing nurse or other healthcare provider involved in the treatment of cancer.

Registration for clinicians in practice »
 
Standby registration for nonclinicians/industry professionals*

For all other professionals, we are unable to confirm seating at this time. If you would like to stand by for participation in this event, please provide your contact information. Should seats become available for the program, we will notify you.

Standby registration for other/industry professionals »

* Individuals employed by for-profit organizations, including financial institutions, biotech or pharmaceutical companies
Registration for groups
If you are registering a group (more than 1 person) for this event, please contact us at Meetings@ResearchToPractice.com or (800) 233-6153.
To ensure seating, please check in at our onsite registration desk at least 30 minutes before the start of the meeting. We cannot guarantee seating after the start of the program.

Meal service will be provided to those who attend the program, based on availability.

Photography and/or video recording may be taken during the educational program by Research To Practice and used in future CNE programs.

Research To Practice fully complies with the legal requirements of the ADA. If you are in need of assistance (ie, physical, dietary, et cetera), please contact us prior to the event at (800) 233-6153.